江南化工(002226.SZ):下屬海外公司中標12.47億元斯瓦科普鈾業採礦一體化項目
格隆匯5月12日丨江南化工(002226.SZ)公佈,公司下屬海外公司北方礦業科技服務(納米比亞)有限公司(簡稱“北礦服(納米比亞)公司”)近日收到斯瓦科普鈾業有限公司出具的《中標通知書》,確認北礦服(納米比亞)公司為“納米比亞湖山鈾礦2號礦坑二期、三期採礦一體化項目”中標單位。中標金額約人民幣12.47億元,約佔公司2021年度經審計營業收入的19.24%。
據悉,斯瓦科普鈾業有限公司為中國廣核集團有限公司下屬子公司。如項目順利實施,預計將對公司未來經營業績產生較為積極的影響。同時,將有利於進一步提升公司國際化業務水平,擴大礦山總承包業務規模。有利於公司向服務製造型企業轉變,優化產業結構,加快“一體化”佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.